Washington Dc, DCNCT06548828Now EnrollingIRB Ready

Gestational Diabetes Mellitus in Pregnancy Clinical Trial in Washington Dc, DC

Access cutting-edge gestational diabetes mellitus in pregnancy treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.

Sponsored by George Washington University

Quick Self-Assessment

See if you qualify for this Washington Dc location

Preparing your pre-screening questions…

Expert Care in Washington Dc

Access gestational diabetes mellitus in pregnancy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related gestational diabetes mellitus in pregnancy treatment provided free

Apply for This Washington Dc Location

Check if you qualify for this gestational diabetes mellitus in pregnancy clinical trial in Washington Dc, DC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Washington Dc

    Convenient for DC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Washington Dc site if eligible
  4. 4Begin participation

About This Gestational Diabetes Mellitus in Pregnancy Study in Washington Dc

The effects of consuming non-nutritive sweeteners (NNS) during pregnancy and lactation on infant obesity and cardiometabolic disease risk are not well understood. In this project, pregnant women who frequently consume NNS will be randomly assigned to an NNS-restriction intervention (NNS restriction during pregnancy and lactation or during lactation only) or a control group (no NNS restriction) to determine whether NNS consumption during pregnancy and/or lactation affects infant body composition, maternal blood sugar during pregnancy, and the infants' gut microbiome and metabolome. The results of this study have the potential to shape recommendations around NNS consumption during pregnancy and lactation, thereby potentially improving maternal and infant metabolic health and reducing the global burden of obesity and cardiometabolic disease.

Sponsor: George Washington University

Who Can Participate

Inclusion Criteria

≤ 16 weeks gestation
Singleton pregnancy
Report frequent NNS beverage consumption (≥ 7 servings/week)
18-45 years of age
Able to read English at a 5th grade level; and
Intend to breastfeed for at least the first 6 months of life.
For infants: The mother must be enrolled and provide assent for the infant to participate.

Exclusion Criteria

Physical or mental concerns preventing study participation;
Medication (e.g., metformin; GLP-1 agonists) use that may affect body weight, body composition, insulin resistance, or lipid profiles;
Tobacco or drug use during pregnancy;
Alcohol consumption (\>1 drink per week) during pregnancy;
Pre-existing gastrointestinal, inflammatory, or malabsorptive disorders (e.g., - Crohn's disease, ulcerative colitis, inflammatory bowel disease) that may impact NNS absorption or gut microbiota;
Known suspected/confirmed genetic fetal abnormalities or suspected or known congenital birth defects.
History of prior gastric bypass surgery.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Washington Dc?

Yes, this clinical trial (NCT06548828) has an active research site in Washington Dc, DC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Gestational Diabetes Mellitus in Pregnancy Treatment Options in Washington Dc, DC

If you're searching for gestational diabetes mellitus in pregnancy treatment options in Washington Dc, DC, this clinical trial (NCT06548828) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gestational diabetes mellitus in pregnancy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all gestational diabetes mellitus in pregnancy clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Washington Dc, DC

See all essential tremor clinical trials recruiting in Washington Dc — not just this study.

Browse Essential Tremor Trials in Washington Dc

Ready to Join in Washington Dc?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Washington Dc, DC